Although the molecular mechanisms responsible for the FAAH and MAGL effects against neuropathology of AD remain to be determined, the findings reported so far support that FAAH and MAGL would be promising therapeutic targets for preventing and treating AD. The gene discussed is MGLL; the disease is Alzheimer disease.